Paul A. Friedman
2021 - Synta Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $423,239 |
|---|---|
| Option Awards | $4,267,500 |
| Salary | $627,650 |
| Total | $5,318,389 |
Friedman received $4.3M in option awards, accounting for 80% of the total pay in 2021.
Friedman also received $423.2K in non-equity incentive plan and $627.7K in salary.
Rankings
In 2021, Paul A. Friedman's compensation ranked 2,434th out of 12,415 executives tracked by ExecPay. In other words, Friedman earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,434 out of 12,415 | 80th |
Division Manufacturing | 964 out of 5,505 | 83rd |
Major group Chemicals And Allied Products | 367 out of 2,375 | 85th |
Industry group Drugs | 319 out of 2,096 | 85th |
Industry Pharmaceutical Preparations | 210 out of 1,546 | 86th |
Pay ratio
| Paul A. Friedman's Pay | $5,318,389 |
|---|---|
| Median Employee's Pay | $459,419 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Paul A. Friedman was $5,318,389.
The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.
The ratio of Paul A. Friedman's pay to the pay of median employee was therefore 12 to one.
Friedman's colleagues
We found five more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2021.
2021
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
2021
Rebecca Taub
Synta Pharmaceuticals
Chief Medical Officer
2021
Marc Schneebaum
Synta Pharmaceuticals
Chief Financial Officer
2021
Brian Lynch
Synta Pharmaceuticals
General Counsel
2021
Remy Sukhija
Synta Pharmaceuticals